Merck, 581302-U, Ascentis® C18 HPLC Column

General description
The Ascentis family of columns is the fourth generation of HPLC column technology from Supelco scientists. Ascentis columns are bonded on high purity, 100 Angstrom silica including 3, 5, and 10 micron particle size. Columns are designed for small molecule applications and are scalable from micro columns (1.0 mm I.D.) to preparative dimensions (50 mm I.D.). The family includes C18, C8, Phenyl, Si and embedded polar group phase, RP-Amide.

Ascentis C18 is an extremely stable and reliable first choice HPLC column that gives symmetric peak shape and excellent retention even for difficult compounds.
Application

A Comparative Study on Analysis of Ginsenosides in American Ginseng Root Residue by HPLC-DAD-ESI-MS and UPLC-HRMS-MS/MS.: This paper compares methodologies involving the Ascentis® C18 HPLC Column for analyzing ginsenosides, showcasing the column′s utility in herbal medicine research (Hsu et al., 2022).

Validation of a Rapid and Easy-to-Apply Method to Simultaneously Quantify Co-Loaded Dexamethasone and Melatonin PLGA Microspheres by HPLC-UV: Encapsulation Efficiency and In Vitro Release.: Demonstrates the use of the Ascentis® C18 HPLC Column in developing a validated HPLC-UV method for analyzing complex drug delivery systems, highlighting the column′s versatility (Brugnera et al., 2022).

Simultaneous determination of ivermectin, clorsulon and their related substances in an injectable finished product by a stability-indicating RP-HPLC method.: Utilizes the Ascentis® C18 HPLC Column to ensure the stability and quality of veterinary pharmaceuticals, underlining the column′s application in regulatory compliance (Padivitage et al., 2022).

Features and Benefits
Excellent retention
Symmetric peak shape
High reproducibility
Complete LC-MS compatibility

Other Notes
Discover LiChropur reagents ideal for HPLC or LC-MS analysis
Legal Information
Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany